Newsfeeds - Spark Newswire

4 minute read

Why Is Ayala Pharmaceuticals Trading Higher By Around 130%? 45 Stocks Moving In Tuesday’s Mid-Day Session

Today, 10:55 PM

Gainers Ayala Pharmaceuticals, Inc. (NASDAQ: AYLA) jumped 130% to $2.0001 after the company filed a request for the withdrawal of the Registration Statement on Form S-1.

AAMC

1 minute read

Oppenheimer Assumes Evaxion Biotech at Outperform, Announces Price Target of $16

By Benzinga Newsdesk

Today, 10:55 PM

Oppenheimer analyst Jeff Jones assumes Evaxion Biotech (NASDAQ:EVAX) with a Outperform rating and announces Price Target of $16.

EVAX

1 minute read

Evaxion Biotech To Test EVX-03 DNA Vaccine For Non-Small Cell Lung Cancer

By Vandana Singh

Today, 10:55 PM

Evaxion Biotech A/S (NASDAQ:EVAX) has selected EVX-03 as the product candidate within its DNA technology platform to target a new indication…

EVAX

5 minute read

Evaxion Biotech Secures Equity Financing Of Up To $40M From Lincoln Park Capital

By Benzinga Newsdesk

Today, 10:55 PM

Evaxion Biotech Secures Equity Financing of up to $40 Million from Lincoln Park Capital COPENHAGEN, Denmark, June 07, 2022 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ:EVAX) ("Evaxion" or the

EVAX

2 minute read

Movers

12 Health Care Stocks Moving In Wednesday’s After-Market Session

By Benzinga Insights

Today, 10:55 PM

Gainers

CLPT

4 minute read

52 Stocks Moving In Wednesday’s Mid-Day Session

By Lisa Levin

Today, 10:55 PM

Gainers Trecora Resources (NYSE: TREC) shares jumped 26.6% to $9.56 as the company agreed to be acquired by an affiliate of Balmoral Funds at $9.81 per share in cash or an enterprise value of $247 million.

ASRT

12 minute read

Earnings Scheduled For May 11, 2022

By Benzinga Insights

Today, 10:55 PM

Companies Reporting Before The Bell • Great Elm Capital (NASDAQ:GECC) is expected to report earnings for its first quarter.

ACOR

1 minute read

Evaxion Biotech Q4 EPS $(0.39) Down From $(0.27) YoY

By Bill Haddad

Today, 10:55 PM

Evaxion Biotech (NASDAQ:EVAX) reported quarterly losses of $(0.39) per share. This is a 44.44 percent decrease over losses of $(0.27) per share from the same period last year.

EVAX